| Keith H Leyden, MD | |
|
11511 Ne 10th St, Bellevue, WA 98004-8578 | |
| (425) 502-3000 | |
| Not Available |
| Full Name | Keith H Leyden |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 11511 Ne 10th St, Bellevue, Washington |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1710021209 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | MD00025598 (Washington) | Primary |
| Entity Name | Kaiser Foundation Health Plan Of Washington |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396810701 PECOS PAC ID: 9032022579 Enrollment ID: O20031112000454 |
News Archive
Minimally invasive techniques have become standard for many procedures, from the removal of the gallbladder to angioplasty, but the approach is now only beginning to be available to patients with spinal conditions. The surgical team at NewYork-Presbyterian Hospital/Columbia University Medical Center's Spine Center aims to bring the benefits of minimally invasive surgery for patients with intractable back pain, stenosis, spinal deformity, even spinal cancer.
GlaxoSmithKline (GSK) has announced that its new drug application (NDA) for ORAL HYCAMTIN (topotecan) capsules, a treatment for relapsed small cell lung cancer (SCLC), has been granted Priority Review by the United States Food and Drug Administration (FDA).
Cancer Research UK scientists have discovered how a combination of two chemotherapy drugs - already showing promise in clinical trials - destroys pancreatic cancer cells, according to research published in Cancer Discovery.
More and more strains of bacteria are developing resistance to previously life-saving antibiotics. Researchers at TUM, the Technische Universitaet Muenchen, have shed light on a metabolic step that appears in many aggressive microorganisms - such as tuberculosis and malaria pathogens - and that may provide a promising target for a new class of antibiotics. The researchers present their results in the chemistry journal Angewandte Chemie.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Keith H Leyden, MD 11511 Ne 10th St, Bellevue, WA 98004-8578 Ph: (425) 502-3000 | Keith H Leyden, MD 11511 Ne 10th St, Bellevue, WA 98004-8578 Ph: (425) 502-3000 |
News Archive
Minimally invasive techniques have become standard for many procedures, from the removal of the gallbladder to angioplasty, but the approach is now only beginning to be available to patients with spinal conditions. The surgical team at NewYork-Presbyterian Hospital/Columbia University Medical Center's Spine Center aims to bring the benefits of minimally invasive surgery for patients with intractable back pain, stenosis, spinal deformity, even spinal cancer.
GlaxoSmithKline (GSK) has announced that its new drug application (NDA) for ORAL HYCAMTIN (topotecan) capsules, a treatment for relapsed small cell lung cancer (SCLC), has been granted Priority Review by the United States Food and Drug Administration (FDA).
Cancer Research UK scientists have discovered how a combination of two chemotherapy drugs - already showing promise in clinical trials - destroys pancreatic cancer cells, according to research published in Cancer Discovery.
More and more strains of bacteria are developing resistance to previously life-saving antibiotics. Researchers at TUM, the Technische Universitaet Muenchen, have shed light on a metabolic step that appears in many aggressive microorganisms - such as tuberculosis and malaria pathogens - and that may provide a promising target for a new class of antibiotics. The researchers present their results in the chemistry journal Angewandte Chemie.
› Verified 2 days ago
Dr. Stephen I Tilghman, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 15325 Se 30th Pl Ste 200, Bellevue, WA 98007 Phone: 425-641-4451 Fax: 425-641-7640 | |
Salma F Gharib, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 11511 Ne 10th St, Bellevue, WA 98004 Phone: 425-502-3000 | |
Stephen W Marshall, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1035 116th Avenue Ne, Bellevue, WA 98004 Phone: 425-688-5759 Fax: 425-688-5101 | |
Marcus A Trione, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1035 116th Avenue Ne, Bellevue, WA 98004 Phone: 425-688-5759 Fax: 425-688-5101 | |
Dr. Lawrence Chu, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 5623 168th Pl Se, Bellevue, WA 98006 Phone: 425-746-3515 | |
Cory Heidelberger, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1035 116th Ave Ne, Bellevue, WA 98004 Phone: 425-688-5759 | |
Dr. Benjamin Andrew Savitch, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1035 116th Ave Ne, Bellevue, WA 98004 Phone: 425-688-5759 |